First American Trust FSB Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

First American Trust FSB cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,900 shares of the healthcare conglomerate’s stock after selling 505 shares during the quarter. First American Trust FSB’s holdings in UnitedHealth Group were worth $961,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. State Street Corp increased its position in UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares in the last quarter. Geode Capital Management LLC raised its stake in UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after acquiring an additional 318,039 shares during the period. Franklin Resources Inc. increased its stake in shares of UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in shares of UnitedHealth Group by 0.5% during the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock valued at $4,012,218,000 after buying an additional 36,394 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in UnitedHealth Group by 3.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate’s stock worth $3,148,134,000 after buying an additional 182,361 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 0.0 %

Shares of NYSE UNH opened at $516.94 on Tuesday. The business’s 50 day moving average price is $509.71 and its 200-day moving average price is $546.15. The company has a market cap of $472.85 billion, a price-to-earnings ratio of 33.35, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $5.83 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 54.19%.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.